Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 100 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Anujan R.

United States

USD 100 /hr

Postdoctoral Fellow in Bioengineering at Harvard | Expert in Drug Delivery and Immunotherapy | 6+ years of experience

Profile Summary

I have PhD-MBA dual degree in Biomedical Engineering . My area of interest is primarily in the field of immune engineering, and my research briefly focuses on (1) Identifying novel targets involved in immune cell -disease cell interactions (2) Engineering drug delivery systems that can modulate immune cell response in order to resolve disease associated with the immune system (3) Develop tools to monitor the efficacy of treatments in real- time

Subject Matter Expertise

• ★ Nanotechnology & Nanomaterials
• ★ Drug Development
• ★ Immunotherapy
• ☆ Materials Science & Engineering
• ☆ Biotechnology & Bioengineering
• ☆ Biomedical Engineering
• ☆ Drug Discovery
• ☆ Drug Formulation
• ☆ Allergy & Clinical Immunology
• ☆ Clinical Immunology
• ☆ Women's Health
• ☆ Breast Cancer

Services

• Research
• Consulting
• Product Development

Research Market Research, Feasibility Study, Gap Analysis

Consulting Business Strategy Consulting, Go-to-Market Strategy Consulting, Scientific and Technical Consulting

Product Development Formulation, Stability/Shelf Life Testing, Concept Development, Reverse Engineering

Work Experience

Postdoctoral Fellow

Harvard University- Wyss Institute

April 2023 - Present

PhD Candidate

University of Massachusetts Amherst

August 2019 - Present

Research Assistant

University of Massachusetts Amherst

May 2017 - August 2019

Research Assistant

Brigham and Women's Hospital

January 2017 - May 2017

Education

Biomedical Engineering

University of Massachusetts Amherst

September 2019 - May 2023

Master of Business Administration

University of Massachusetts Amherst

September 2019 - May 2023

B.Tech (Bioengineering )

SASTRA University

July 2013 - July 2017

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Anujan Ramesh, Vaishali Malik, Anthony Brouillard, Ashish Kulkarni (2022). Supramolecular nanotherapeutics enable metabolic reprogramming of tumor‐associated macrophages to inhibit tumor growth . Journal of Biomedical Materials Research Part A.

Anujan Ramesh and Vaishali Malik and Hayat Anu Ranjani and Harriet Smith and Ashish A. Kulkarni(2021). Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor–loaded nanoparticle enhances anticancer efficacy . Drug Delivery and Translational Research. Springer Science and Business Media {LLC}

Vaishali Malik and Anujan Ramesh and Ashish A. Kulkarni(2021). TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy . Advanced Therapeutics. 4. (8). p. 2100086. Wiley

Anujan Ramesh, Anthony Brouillard, Ashish Kulkarni(2021). Supramolecular Nanotherapeutics for Macrophage Immunotherapy . ACS Applied Bio Materials. 4. (6). p. 4653--4666. American Chemical Society ({ACS})

Anh Nguyen and Anujan Ramesh and Sahana Kumar and Dipika Nandi and Anthony Brouillard and Alexandria Wells and Leonid Pobezinsky and Barbara Osborne and Ashish A. Kulkarni(2020). Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy . Science Advances. 6. (40). p. eabc2777. American Association for the Advancement of Science ({AAAS})

Anujan Ramesh and Sahana Kumar and Anthony Brouillard and Dipika Nandi and Ashish Kulkarni(2020). A Nitric Oxide (NO) Nanoreporter for Noninvasive Real‐Time Imaging of Macrophage Immunotherapy . Advanced Materials. 32. (24). p. 2000648. Wiley

Sahana Kumar, Anujan Ramesh, Ashish Kulkarni(2020). Targeting macrophages: a novel avenue for cancer drug discovery . Expert Opinion on Drug Discovery. p. 1--14. Informa {UK} Limited

(2020). Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy . Biomaterials.

Anujan Ramesh, Sahana Kumar, Anh Nguyen, Anthony Brouillard, Ashish Kulkarni(2020). Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy . Nanoscale. Royal Society of Chemistry ({RSC})

Nilesh Deshpande and Anujan Ramesh and Dipika Nandi and Anh Nguyen and Anthony Brouillard and Ashish Kulkarni(2020). Supramolecular Polysaccharide Nanotheranostics that Inhibit Cancer Cells Growth and Monitor Targeted Therapy Response . Nanotheranostics. 4. (3). p. 156--172. Ivyspring International Publisher

(2019). CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages . Advanced Materials.

(2019). Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint Inhibitor . Cellular and Molecular Bioengineering.

(2018). A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer . Nature biomedical engineering.

BOOK CHAPTER

Anujan Ramesh and Ashish A. Kulkarni(2022). Delivery strategies for reprogramming tumor-associated macrophages . Systemic Drug Delivery Strategies. p. 83--115. Elsevier